Comparison between glypican-3 and alpha-fetoprotein in discrimination of hepatocellular carcinoma from cirrhotic patients
Last updated: 25 Dec 2024
10.21608/jbaar.2018.154438
AFP, Glypican-3, Liver cirrhosis, HCC, Blood markers, Diagnosis
Abdelfattah
Attallah
M.
Research & Development Department, Biotechnology Research Center, New Damietta, Egypt
amattallah@hotmail.com
Mohamed
El-Far
Abd El-Hafez
Chemistry department, Faculty of Science, Mansoura University, Mansoura, Egypt
Mohamed
Omran
Mostafa
Chemistry department, Faculty of Science, Helwan University, Helwan, Egypt
drmmomran@yahoo.com
0000-0001-8557-3104
Aya
Saeed
Mohamed
Research & Development Department, Biotechnology Research Center, New Damietta City, Egypt
Mohamed
Elbendary
Sayed
Research & Development Department, Biotechnology Research Center, New Damietta City, Egypt
Kareem
Attallah
Abdelfattah
Research & Development Department, Biotechnology Research Center, New Damietta City, Egypt
Khaled
Mari
Farid
Tropical medicine department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
4
4
22148
2018-12-01
2018-09-22
2018-12-08
459
468
2356-9174
2356-9182
https://jbaar.journals.ekb.eg/article_154438.html
https://jbaar.journals.ekb.eg/service?article_code=154438
11
Original Article
1,272
Journal
Journal of Bioscience and Applied Research
https://jbaar.journals.ekb.eg/
Comparison between glypican-3 and alpha-fetoprotein in discrimination of hepatocellular carcinoma from cirrhotic patients
Details
Type
Article
Created At
22 Jan 2023